A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors

MLA

Stefano Ferrari, et al. “A Phase II Multicenter, Open-Label, Clinical and Pharmokinetic Trial of PM00104 in Patients with Advanced Ewing Family of Tumors.” Investigational New Drugs, vol. 32, Nov. 2013, pp. 171–77. EBSCOhost, https://doi.org/10.1007/s10637-013-0037-6.

APA

Stefano Ferrari, Mariano Siguero, Robin L. Jones, Sant P. Chawla, Neelesh Soman, Jean-Yves Blay, Vicente Alfaro, Fariba Navid, & Pilar Lardelli. (2013). A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors. Investigational New Drugs, 32, 171–177. https://doi.org/10.1007/s10637-013-0037-6

Chicago

Stefano Ferrari, Mariano Siguero, Robin L. Jones, Sant P. Chawla, Neelesh Soman, Jean-Yves Blay, Vicente Alfaro, Fariba Navid, and Pilar Lardelli. 2013. “A Phase II Multicenter, Open-Label, Clinical and Pharmokinetic Trial of PM00104 in Patients with Advanced Ewing Family of Tumors.” Investigational New Drugs 32 (November): 171–77. doi:10.1007/s10637-013-0037-6.